Kezar Life Sciences Income Statement (2021-2025) | KZR

Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -0.16M-0.25M-0.27M-0.37M-0.39M7.00M-0.40M-0.40M-0.35M-0.30M
Operating items
Research & Development 9.34M10.53M9.78M10.94M11.35M13.86M14.86M18.32M21.00M23.74M22.64M17.17M16.30M16.24M16.03M12.18M9.58M
Selling, General & Administrative 3.67M3.97M4.32M4.93M4.98M5.07M5.17M6.21M5.79M8.79M5.76M6.54M5.60M5.71M5.54M5.45M5.02M
Other Operating Expenses 6.19M1.48M-0.01M
Operating Expenses 13.01M14.50M14.10M15.88M16.32M18.93M20.03M24.52M26.78M32.53M34.59M23.71M23.38M21.95M21.56M17.63M14.60M
Operating Income -13.01M-14.50M-14.10M-15.88M-16.32M-18.93M-20.03M-24.52M-26.78M-25.53M-34.59M-23.71M-23.38M-21.95M-21.56M-17.63M-14.60M
EBIT -13.01M-14.50M-14.10M-15.88M-16.32M-18.93M-20.03M-24.52M-26.78M-25.53M-34.59M-23.71M-23.38M-21.95M-21.56M-17.63M-14.60M
Non-operating items
Interest & Investment Income 0.05M0.04M0.05M0.11M0.41M1.39M2.20M2.69M2.86M2.82M2.73M2.45M2.24M2.04M1.73M1.42M1.20M
Net income details
EBT -12.96M-14.46M-14.21M-16.02M-16.19M-17.85M-18.18M-22.20M-24.31M-23.10M-32.26M-21.66M-21.55M-20.31M-20.22M-16.56M-13.70M
Profit After Tax -12.96M-14.46M-14.21M-16.02M-16.19M-17.85M-18.18M-22.20M-24.31M-23.10M-32.26M-21.66M-21.55M-20.31M-20.22M-16.56M-13.70M
Income from Continuing Operations -12.96M-14.46M-14.21M-16.02M-16.19M-17.85M-18.18M-22.20M-24.31M-23.10M-32.26M-21.66M-21.55M-20.31M-20.22M-16.56M-13.70M
Consolidated Net Income -12.96M-14.46M-14.21M-16.02M-16.19M-17.85M-18.18M-22.20M-24.31M-23.10M-32.26M-21.66M-21.55M-20.31M-20.22M-16.56M-13.70M
Income towards Parent Company -12.96M-14.46M-14.21M-16.02M-16.19M-17.85M-18.18M-22.20M-24.31M-23.10M-32.26M-21.66M-21.55M-20.31M-20.22M-16.56M-13.70M
Net Income towards Common Stockholders -12.96M-14.46M-14.21M-16.02M-16.19M-17.85M-18.18M-22.20M-24.31M-23.10M-32.26M-21.66M-21.55M-20.31M-20.22M-16.56M-13.70M
Additional items
EPS (Basic) -0.25-0.28-0.26-0.26-0.25-0.25-9.37-0.31-0.34-3.18-4.44-2.98-2.96-2.78-2.77-2.27-1.87
EPS (Weighted Average and Diluted) -0.25-0.28-0.26-0.26-0.25-0.25-9.37-0.31-0.34-3.18-4.44-2.98-2.96-2.78-2.77-2.27-1.87
Shares Outstanding (Weighted Average) 51.06M51.90M52.05M52.76M60.63M64.28M72.15M6.74M72.33M72.46M7.27M7.26M7.28M7.28M7.30M7.29M7.31M7.31M7.32M
Shares Outstanding (Diluted Average) 51.90M52.05M52.76M60.63M64.28M72.15M6.74M72.33M72.46M7.27M7.26M7.28M7.28M7.30M7.29M7.31M7.31M7.32M
EBITDA -13.01M-14.50M-14.10M-15.88M-16.32M-18.93M-20.03M-24.52M-26.78M-25.53M-34.59M-23.71M-23.38M-21.95M-21.56M-17.63M-14.60M
Interest Expenses 0.16M0.25M0.27M0.31M0.35M0.37M0.39M0.40M0.40M0.40M0.40M0.40M0.39M0.35M0.30M
Shares Outstanding 48.08M48.15M48.60M56.26M59.56M68.34M68.37M6.85M7.08M7.25M7.27M7.28M7.28M7.29M7.30M